Clinical management of TGCT is guided by classic serum tumor markers (lactate dehydrogenase [LDH], alpha-fetoprotein [AFP], and beta-human chorionic gonadotropin [β-hCG]) and imaging diagnostics14. Here, AFP is linked to neoplasm.